Elevated alkaline phosphatase with raltegravir in a treatment experienced HIV patient.
Fleischbein
Eric
E
O'Brien
John
J
Martelino
Ryan
R
Fenstersheib
Martin
M
D000469:Alkaline Phosphatase / Q000378:metabolism*; D000069446:Atazanavir Sulfate; D018791:CD4 Lymphocyte Count; D004347:Drug Interactions; D024882:Drug Resistance, Viral; D015658:HIV Infections / Q000188:drug therapy* / Q000235:genetics; D015497:HIV-1; D006801:Humans; D008297:Male; D008875:Middle Aged; D009842:Oligopeptides / Q000009:adverse effects* / Q000627:therapeutic use; D011725:Pyridines / Q000009:adverse effects* / Q000627:therapeutic use; D011760:Pyrrolidinones / Q000009:adverse effects* / Q000627:therapeutic use; D000068898:Raltegravir Potassium
D009842:Oligopeptides; D011725:Pyridines; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium; D000069446:Atazanavir Sulfate; D000469:Alkaline Phosphatase